Blood Bupivacaine Concentration After Regional Block Applications in Pediatric Patients
1 other identifier
interventional
20
1 country
1
Brief Summary
Analgesia methods such as systemic analgesics, quadratus lumborum block, and transversus abdominis plane block are used for pain management after lower abdominal surgery. Quadratus lumborum block (QLB) requires the patient to be in the lateral decubitus position, and the drug injection point is deeper. Transversus abdominis plane (TAP) block, on the other hand, can be performed with the patient supine, and the drug injection point is more superficial. However, while TAP block has no effect on visceral pain, QLB is also effective in visceral pain. Furthermore, although the injection point for QLB is deep, systemic absorption of the drug is expected to be lower than with TAP block due to its distance from vascular structures. Consequently, blood local anesthetic concentrations and the risk of local anesthetic systemic toxicity (LAST) are also expected to be lower. Despite the deeper injection, it is expected to provide better analgesia and a lower risk of LAST, making it superior to TAP block. This study aimed to compare the postoperative pain relief effect of quadratus lumborum block and transversus abdominis plane block, routinely performed in the clinic to prevent postoperative pain in pediatric patients undergoing inguinal hernia surgery, using the FLACC (Face, Leg Mobility, Activity, Crying, and Consolability) score for blood bupivacaine dose after drug injection. Based on these data, if lower blood drug concentrations are detected in patients undergoing QLB, the investigators aim to implement this technique routinely in clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2025
CompletedFirst Posted
Study publicly available on registry
December 1, 2025
CompletedStudy Start
First participant enrolled
January 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2026
ExpectedDecember 17, 2025
December 1, 2025
3 months
November 20, 2025
December 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Blood bupivacaine level
After the block application, 2 mL of blood will be taken into a routine biochemistry tube and the blood bupivacaine level will be measured.
30 and 60 minutes after block application
FLACC (Face, Leg Mobility, Activity, Crying, Consolation)
To compare postoperative pain efficacy with FLACC (Face, Leg Mobility, Activity, Crying, Consolability) Minimum score is 0 (no pain), maximum score 10 (the worse pain).
0.HOUR, 1.HOUR, 2.HOUR, 4.HOUR, 6.HOUR, 12.HOUR 24.HOUR
Study Arms (2)
GROUP USING Transversus Abdominis Plane Block
ACTIVE COMPARATORAfter induction of general anesthesia in all patients, once airway security is ensured, the standard regional anesthesia technique will be performed under ultrasound guidance by the same physician. A transversus abdominis plane block will be performed using an in-plane approach, passing through the external oblique and internal oblique muscles visible on ultrasound, and then advancing toward the fascial layer separating the internal oblique and transversus abdominis muscles. Following the block, the surgical team will begin the procedure. Thirty and sixty minutes after the block, 2 mL of blood will be collected into a routine biochemistry tube, and the blood bupivacaine level will be measured.
GROUP USING Quadratus Lumborum Block
ACTIVE COMPARATORAfter induction of general anesthesia in all patients, once airway security is ensured, the standard regional anesthesia technique will be performed by the same person under ultrasound guidance. The ultrasound probe is placed transversely, just above the iliac crest in the midaxillary line. After visualizing the vertebral body, transverse process, psoas major, quadratus lumborum, and erector spinae muscles, a local anesthetic will be administered between the quadratus lumborum and psoas major muscles, using an in-plane approach, as visible on ultrasound. Thirty and 60 minutes after the block, 2 mL of blood will be collected in a routine biochemistry tube, and the blood bupivacaine level will be measured.
Interventions
transversus abdominis plane block will be performed using 0.25-0.5% cc/kg bupivacaine
Quadratus Lumborum Block will be performed using 0.25-0.5% cc/kg bupivacaine
Eligibility Criteria
You may qualify if:
- Patients undergoing elective inguinal hernia surgery.
- years of age
- ASA I-II patients
You may not qualify if:
- Vulnerable populations such as those incapacitated, those in intensive care, those unconscious, those unable to give personal consent, or impressionable individuals will not be included in the study.
- Although pediatric patients who may be considered a vulnerable population will be included in the study, patients with serious illnesses such as ASA III-IV will not be included in this group.
- Patients who refuse to participate in the observational study, their parents/legal guardians,
- Patients with incomplete data
- Patients who underwent surgery with an incision other than the planned one for any reason.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kocaeli University
Kocaeli, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 20, 2025
First Posted
December 1, 2025
Study Start
January 25, 2026
Primary Completion
April 25, 2026
Study Completion (Estimated)
June 25, 2026
Last Updated
December 17, 2025
Record last verified: 2025-12